The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine | Zendy

Ghassan Dbaibo | Zendy; Marie Van der Wielen | Zendy; Mariam Reda | Zendy; Fouad Medlej | Zendy; Carelle Tabet | Zendy; Dominique Boutriau | Zendy; Anne Sumbul | Zendy; Sameh Anis | Zendy; Jacqueline M. Miller | Zendy

Open Access

The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine

Author(s) -

Ghassan Dbaibo,

Marie Van der Wielen,

Mariam Reda,

Fouad Medlej,

Carelle Tabet,

Dominique Boutriau,

Anne Sumbul,

Sameh Anis,

Jacqueline M. Miller

Publication year - 2012

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2012.04.006

Subject(s) - toxoid , tetanus , conjugate vaccine , medicine , meningococcal vaccine , vaccination , immunology , virology , immunogenicity , immunization , antigen

The immunogenicity and safety of the tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT) were evaluated in subjects previously vaccinated with a tetravalent meningococcal polysaccharide vaccine and in subjects without previous meningococcal vaccination.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research